Chart, Financials, Historical Prices, Industry, Insider, Messages, Options, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 9-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 43)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
9-Feb-10New Constructs, LLCN/ALLY: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettPlunkett's Health Care Technologies Overview 2010 (Summary)80$199  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettNanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary)34$199  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettEli Lilly & Company (LLY) Profile & Biotech Industry Trends Analysis 201043$149  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettNanotechnology & MEMS Industry Market Research and Competitive Analysis 2009447$299  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettEngineering & Research Industry Market Research and Competitive Analysis 2009729$299  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettEngineering & Research Industry Trends, Statistics & Analysis 2009 (Summary)70$199  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Market Research and Competitive Analysis 2010730$299  View Abstract
Next 20

Brokerage Reports (Showing 1 to 3 of 3)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
29-Jan-10First GlobalKavita Thomas, Devina MehraFirst Global reiterates LT Moderate Outperform on Johnson & Johnson Inc.14$50  View Abstract
12-Jan-10Thomson StreetEventsN/ALLY - Event Transcript of Eli Lilly conference call, Jan. 12, 2010 / 3:00pm ET6$75  View Abstract
30-Dec-09First GlobalKavita Thomas, Devina MehraFirst Global reiterates Moderate Outperform on Sanofi-Aventis15$50  View Abstract

Independent Reports (Showing 1 to 10 of 40)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
9-Feb-10New Constructs, LLCN/ALLY: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettPlunkett's Health Care Technologies Overview 2010 (Summary)80$199View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettNanotechnology & MEMS Industry Trends, Statistics & Analysis 2009 (Summary)34$199View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettEli Lilly & Company (LLY) Profile & Biotech Industry Trends Analysis 201043$149View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettNanotechnology & MEMS Industry Market Research and Competitive Analysis 2009447$299View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotechnology & Genetics Industry Market Research and Competitive Analysis 2010569$299View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettBiotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary)71$199View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettEngineering & Research Industry Market Research and Competitive Analysis 2009729$299View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettEngineering & Research Industry Trends, Statistics & Analysis 2009 (Summary)70$199View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettHealth Care Industry Market Research and Competitive Analysis 2010730$299View Abstract
Next 20

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.